Ana María Franchi Selected Research

Embryo Loss

6/2017	Peripheral Blood Mononuclear Cells Infiltration Downregulates Decidual FAAH Activity in an LPS-Induced Embryo Resorption Model.
1/2017	Evidence for CB2 receptor involvement in LPS-induced reduction of cAMP intracellular levels in uterine explants from pregnant mice: pathophysiological implications.
12/2015	Progesterone modulates the LPS-induced nitric oxide production by a progesterone-receptor independent mechanism.
8/2015	Lipopolysaccharide-induced murine embryonic resorption involves changes in endocannabinoid profiling and alters progesterone secretion and inflammatory response by a CB1-mediated fashion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ana María Franchi Research Topics

Disease

7	Spontaneous Abortion (Miscarriage) 06/2017 - 01/2010
4	Embryo Loss 06/2017 - 08/2015
3	Premature Birth (Birth, Premature) 01/2021 - 01/2017
3	Premature Obstetric Labor (Premature Labor) 11/2017 - 12/2015
3	Infections 12/2015 - 01/2010
2	Inflammation (Inflammations) 11/2017 - 01/2017
1	Maternal Obesity 10/2021
1	Perinatal Death 01/2021
1	Pregnancy Complications 01/2020
1	Brain Injuries (Brain Injury) 11/2017
1	Fetal Death 01/2017
1	Thrombophilia 01/2016
1	Septic Abortion 01/2010

Drug/Important Bio-Agent (IBA)

10	LipopolysaccharidesIBA 01/2021 - 01/2010
6	EndocannabinoidsIBA 06/2017 - 01/2010
2	CytokinesIBA 01/2021 - 12/2015
2	EndotoxinsIBA 01/2017 - 01/2017
2	ProstaglandinsIBA 01/2017 - 12/2015
2	Progesterone FDA LinkGeneric 11/2016 - 08/2015
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 10/2021
1	Biological ProductsIBA 01/2021
1	MelatoninIBA 11/2017
1	Neuroprotective AgentsIBA 11/2017
1	Tocolytic Agents (Tocolytics)IBA 01/2017
1	ResveratrolIBA 01/2017
1	CannabinoidsIBA 12/2016
1	Therapeutic UsesIBA 12/2016
1	Heparin (Liquaemin)FDA LinkGeneric 01/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2015
1	LigandsIBA 08/2015
1	anandamide (arachidonylethanolamide)IBA 01/2010

Therapy/Procedure

1	Therapeutics 01/2020